MediQuality

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

MediQuality - overview

Established

2000

Location

Louvain-la-Neuve, -, Belgium

Primary Industry

Healthcare IT

About

MediQuality offers digital health solutions that enhance patient care and streamline healthcare operations through a platform designed for medical professionals, enabling efficient access to critical health information and telehealth services. Founded in 2000 in Louvain-la-Neuve, Belgium, MediQuality provides digital health solutions focused on improving patient care. In August 2018, MediQuality was acquired by WebMD, LLC, which is part of Internet Brands, KKR, and Temasek Holdings. The founder, Marc Moreau, has been instrumental in the company's vision and direction.


MediQuality specializes in a comprehensive suite of digital health solutions aimed at enhancing patient care and streamlining healthcare operations. Their offerings include a robust platform for medical professionals that improves access to critical health information and telehealth services for remote consultations. The company serves healthcare institutions, medical practitioners, and patients in North America, Europe, and select regions in Asia, addressing the challenges of patient engagement and operational inefficiencies in healthcare. In the most recent year, 2017, MediQuality generated revenue of USD 3.


73 mn and reported an EBITDA of USD -209,390. 3 for the year 2023. The company operates on a subscription-based model for healthcare providers and institutions using their platform and telehealth services, enabling streamlined patient interactions and data sharing. MediQuality's future growth strategy involves the development of new products designed to enhance healthcare delivery, although specific release dates are not disclosed.


The company is also targeting expansion into new markets, including Europe and Asia, by 2024. Recent funding from the acquisition in August 2018 will be utilized to support these initiatives and strengthen their market position.


Current Investors

MH Sub I, LLC, WebMD, LLC

Primary Industry

Healthcare IT

Sub Industries

Epidemiology, Healthcare IT

Website

www.mediquality.net

Verticals

HealthTech

Company Stage

Add-on

Total Amount Raised

Subscriber access only

MediQuality - financials

Fiscal Year EndedMar 31, 2010Mar 31, 2011Mar 31, 2012Mar 31, 2013Mar 31, 2014Mar 31, 2015Mar 31, 2016Mar 31, 2017Mar 31, 2018Mar 31, 2019Dec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024
Revenue (USD)---1,426,2442,143,5981,670,6572,458,6903,399,087-------
% Revenue Growth (YoY)----50.3%(22.1%)47.2%38.2%-------
EBITDA (USD)114,703114,078133,335343,902360,988170,861239,973154,834150,541378,081151,88143,643---
Operating Income (USD)21,33919,625(107,507)129,161103,55546,04092,51453,27174,415256,976(129,828)(181,380)---
Operating Margin---9.1%4.8%2.8%3.8%1.6%-------
% EBITDA Margin---24.1%16.8%10.2%9.8%4.6%-------
NET Income (USD)24,24323,372(108,366)125,096103,44041,61484,02941,58661,809171,78336,395(208,198)---
% Net Margin---8.8%4.8%2.5%3.4%1.2%-------

MediQuality - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompletedMediQuality-

Displaying 1 - 1 of 1

MediQuality - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.